Miriam Caramanti Selected Research

Miriam Caramanti Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 01/2013
4	Hyponatremia 06/2020 - 06/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 01/2013
3	Breast Neoplasms (Breast Cancer) 03/2024 - 03/2013
2	Thymoma (Thymic Carcinoma) 01/2020 - 08/2015
2	Thymus Neoplasms (Thymus Neoplasm) 08/2015 - 05/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2010 - 01/2010
1	Hypoxia (Hypoxemia) 12/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2020
1	Inflammation (Inflammations) 10/2019
1	Inappropriate ADH Syndrome (SIADH) 01/2019
1	Lung Neoplasms (Lung Cancer) 04/2017
1	Adenocarcinoma of Lung 12/2016
1	Lymphopenia (Lymphocytopenia) 05/2016
1	Anemia 03/2016
1	Malignant Mesothelioma 03/2016
1	Embryonal Carcinoma 01/2015
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Triple Negative Breast Neoplasms 06/2014
1	Carcinogenesis 05/2014
1	Heart Failure 10/2013
1	Acute Coronary Syndrome 10/2013
1	Cardiotoxicity 10/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013
1	Ovarian Neoplasms (Ovarian Cancer) 03/2013
1	Neoplasm Metastasis (Metastasis) 03/2013
1	Circulating Neoplastic Cells 03/2013
1	Melanoma (Melanoma, Malignant) 03/2013
1	Thyroid Neoplasms (Thyroid Cancer) 03/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010

Drug/Important Bio-Agent (IBA)

3	SodiumIBA 06/2020 - 04/2017
2	eribulin FDA Link 03/2024 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 08/2015
2	ParaffinIBA 01/2020 - 08/2015
2	Hormones (Hormone)IBA 01/2019 - 06/2016
2	DiureticsIBA 01/2019 - 06/2016
2	Vasopressins (Vasopressin)IBA 01/2019 - 06/2016
2	Endothelin-1 (Endothelin 1)IBA 07/2010 - 01/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010 - 01/2010
2	GhrelinIBA 07/2010 - 01/2010
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2024
1	Pemetrexed (MTA)FDA Link 03/2024
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2020
1	Tumor Biomarkers (Tumor Markers)IBA 06/2020
1	AntigensIBA 06/2020
1	CarbohydratesIBA 06/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2020
1	B7-H1 AntigenIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tolvaptan FDA Link 01/2019
1	AndrogensIBA 12/2016
1	Estrogens (Estrogen)FDA Link 12/2016
1	Progesterone FDA LinkGeneric 12/2016
1	ElectrolytesIBA 06/2016
1	AsbestosIBA 03/2016
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 08/2015
1	DNA (Deoxyribonucleic Acid)IBA 08/2015
1	ChromiumIBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 06/2014
1	SERPIN-B5 (maspin)IBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 03/2013
1	Tyrosine Kinase InhibitorsIBA 01/2013
1	Gefitinib (Iressa)FDA Link 01/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013

Therapy/Procedure

10	Therapeutics 06/2020 - 03/2013
6	Drug Therapy (Chemotherapy) 12/2016 - 10/2013
1	Biological Therapy 01/2016
1	Thymectomy 08/2015
1	Aftercare (After-Treatment) 10/2013